Media Hub
How treatment for chronic kidney disease has evolved over the last 12 months, with associate director of statistical science at AstraZeneca
We asked Samvel Gasparyan, AstraZeneca’s Associate Director of Statistical Science, to reflect on the progress made over the past 12 months in the exciting field of chronic kidney disease drug development.
Alexion Pharmaceuticals on promising opportunities and breakthroughs in the treatment of chronic kidney disease
We spoke to Amit Sharma, Vice President for Clinical Development and Therapeutic Head Nephrology and Hematology at Alexion Pharmaceuticals, on chronic kidney disease
Otsuka’s Executive Director of Medical Strategy, Jay Elliott, shares his thoughts on the most exciting breakthroughs in the CKD space
Download today and learn more about the challenges, developments and innovative drug developments transforming the CKD landscape.